New Funding Brings Personalized CRISPR Cures Closer to Children with Rare Diseases
CALIFORNIA, JUL 8 – The $20 million Center aims to develop personalized CRISPR therapies for eight children with severe genetic diseases and set a model for wider treatment access, Chan Zuckerberg Initiative said.
7 Articles
7 Articles
Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements
CRISPR-based gene activation (CRISPRa) is a strategy for upregulating gene expression by targeting promoters or enhancers in a tissue/cell-type specific manner. Here, we describe an experimental framework that combines highly multiplexed perturbations with single-cell RNA sequencing (sc-RNA-seq) to identify cell-type-specific, CRISPRa-responsive cis-regulatory elements and the gene(s) they regulate. Random combinations of many gRNAs are introduc…
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
SAN FRANCISCO, July 8, 2025 /PRNewswire/ -- Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available. Today, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced…
Center for Pediatric CRISPR Therapies Funded by IGI, CZI
The recent clinical success of treating “Baby KJ” Muldoon—an infant born with a rare metabolic disease—with the first-ever personalized gene-editing therapy brought much-needed enthusiasm to the genome editing world. It also raised a lot of questions: how will this advance develop beyond an n-of-1 therapy? How will genome editing strategies be developed more broadly and brought to more children? Now, the Chan Zuckerberg Initiative (CZI) and the …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium